SAN FRANCISCO, Dec. 12, 2017 (GLOBE NEWSWIRE) — Velano Vasculartoday announced that it was named by FierceMedTech as one of 2017’s Fierce 15 med tech companies, acknowledging the company as one of the most promising private companies in the industry for its breakthrough work addressing the world’s growing vascular access challenges. More than one […]
Other News
PQ Bypass Receives IDE Approval to Initiate Study of First-of-its-Kind Procedure for Patients Suffering From Peripheral Artery Disease
SUNNYVALE, Calif.–(BUSINESS WIRE)–PQ Bypass, Inc., today announced it has received conditional approval of its investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate the pivotal DETOUR II clinical trial. As the first-ever pivotal trial for percutaneous femoropopliteal bypass, DETOUR II will evaluate the safety and […]
Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2018
DUBLIN – December 8, 2017 – The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2018 third quarter cash dividend of $0.46 per ordinary share, representing a 7 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company […]
FierceMedTech Names Endotronix as one of its “Fierce 15” MedTech Companies of 2017
LISLE, Ill., Dec. 11, 2017 /PRNewswire/ — Endotronix, Inc., a digital health medtech company providing innovative solutions for heart failure management, today announced that it has been named by FierceMedTech as one of 2017’s Fierce 15 MedTech companies, recognizing it as one of the most promising private medical technology companies in the industry. “We are honored […]
HeartStitch® Leading the growth of PFO Closure in Italy
MILAN, Dec. 11, 2017 /PRNewswire/ — Kardia announced expansion plan of the NobleStitch™ EL at a recent meeting organized by Professor Francesco Romeo at Policlinico Tor Vergata in Rome where Prof. Achille Gaspardone performed a successful NobleStitch™ EL live case that was transmitted to the attendees in Ayla Magna, Rome, Italy. PFO (PRNewsfoto/HeartStitch) Prof. Gaspardone, who recently presented 2 studies (The […]
BTG plc: Northwestern University Adopts Y90 TARE with TheraSphere® as First-Line Treatment for HCC
LONDON, December 12, 2017 /PRNewswire/ — BTG plc (LSE: BTG), a global specialist healthcare company, today announced that following positive results of its 15-year experience between 2003 and 2017 with TheraSphere®, Northwestern University, Illinois has adopted Y90 transarterial radioembolisation (TARE) with TheraSphere® as the primary trans-arterial loco-regional therapy (LRT) for patients with hepatocellular carcinoma (HCC) limited to the […]
FierceMedTech Names Analytics 4 Life as One of its Fierce 15 MedTech Companies of 2017
RESEARCH TRIANGLE PARK, N.C. and TORONTO, Dec. 12, 2017 /PRNewswire/ — Analytics 4 Life, a digital health company applying the power of artificial intelligence to develop solutions that improve existing care pathways, today announced that it has been named by FierceMedTech as one of 2017’s Fierce 15 medtech companies, designating it as one of the most promising […]
New Dashboard Application from Siemens Healthineers Provides Insights into Cardiology Operations
Siemens Healthineers has launched teamplay Cardio, a new cardiology dashboard application within the Siemens Healthineers Digital Ecosystem. Part of teamplay—the company’s cloud-based network that enables access to metrics from a facility’s imaging fleet—this new application helps cardiology departments better understand their performance and status. teamplay Cardio uses actionable data to […]
AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018
LATHAM, N.Y.–(BUSINESS WIRE)– AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report financial results for the second quarter of fiscal year 2018 before the market open on Thursday, January 4, 2018. The Company’s management will […]
AliveCor Granted Patent for Proactive Notification of Possible Heart Arrhythmias
MOUNTAIN VIEW, Calif., Dec. 12, 2017 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (EKG) technology, today announced issuance of a U.S. patent which covers the use of data collected from wearable devices as a means of assisting diagnoses of heart arrhythmias, including those that may be asymptomatic. U.S. Patent […]



